ELCC Action Center
Stay current with the latest advances shaping the future of thoracic oncology with the ELCC Action Center. This series brings together expert analysis, clinical perspectives, and key takeaways from the European Lung Cancer Congress (ELCC), one of the leading global meetings dedicated to lung cancer research and treatment innovation.
Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
AudioAbstractsAlectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
Ryan Quigley
The Epigenetics of Lung Cancer Dormancy and Relapse
Project Oncology®The Epigenetics of Lung Cancer Dormancy and Relapse
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Project Oncology®Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Project Oncology®ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
AudioAbstractsAre E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
Ryan Quigley
- advertisement
- 03/24/2026
- 03/24/2026
- 03/24/2026